Learn / CGEM
NASDAQ: CGEM
Cullinan Therapeutics (CGEM) stock, explained like you're 5
Cullinan Therapeutics trades on the Nasdaq under the ticker CGEM. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 999 million dollars.
- Ticker
- CGEM
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Small cap, about 999 million dollars
Is Cullinan Therapeutics a small, medium or large cap company?
No. Cullinan Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 999 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Cullinan Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves CGEM stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Earnings Calendar for: (Yahoo Finance)
- Ellsworth Advisors LLC Buys New Stake in Cullinan Therapeutics, Inc. $CGEM (MarketBeat)
- CGEM Mar 2027 30.000 put (CGEM270319P00030000) stock price, news, quote and history (Yahoo Finance UK)
- CGEM Jun 2027 27.000 put (CGEM270617P00027000) stock historical prices and data (Yahoo Finance UK)
- CGEM Oct 2026 18.000 put (CGEM261016P00018000) interactive stock chart (Yahoo Finance UK)
Follow CGEM in your daily brief
Each trading day at 5 PM ET we post what happened to Cullinan Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow CGEM
Questions about Cullinan Therapeutics stock
What does Cullinan Therapeutics do?
Cullinan Therapeutics trades on the Nasdaq under the ticker CGEM. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 999 million dollars.
What is the ticker symbol for Cullinan Therapeutics?
Cullinan Therapeutics trades under the ticker CGEM on the Nasdaq.
What is Cullinan Therapeutics's market cap?
Cullinan Therapeutics is a small cap stock with a market cap of about 999 million dollars.
How does Cullinan Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves CGEM stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow CGEM stock every day?
Add CGEM to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.